Search clinical trials for: refractory constipation

Total 10112 results

Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Biological Therapy in Treating Patients With Myelodysplastic Syndrome

Myelodysplastic Syndromes | Leukemia

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

Myelodysplastic Syndromes | Leukemia

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors

Sarcoma | Lymphoma | Kidney Cancer | Testicular Germ Cell Tumor | Breast Cancer | Ovarian Cancer | Gestational Trophoblastic Tumor | Neuroblastoma

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation

Cancer

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome

Myelodysplastic Syndromes | Leukemia

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)

Completed

Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon

Lymphoma | Kidney Cancer | Myelodysplastic Syndromes | Leukemia | Testicular Germ Cell Tumor | Breast Cancer | Chronic Myeloproliferative Disorders | Ovarian Cancer | Gestational Trophoblastic Tumor | Neuroblastoma | Multiple Myeloma and Plasma Cell Neoplasm | Graft Versus Host Disease

United States
Fred Hutchinson Cancer Center
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute...

Completed

Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic Disease

Lymphoma | Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative Diseases

United States
Mahidol University

Completed

Hydroxyzine for the Prevention of Pruritus From Spinal Morphine in Transabdominal Hysterectomy Patients (TAH)

Nausea | Vomiting | Pruritus

Thailand
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Research Study of JNJ-26854165 to Determine the Safety and Dose in Patients With Advanced Stage or Refractory Solid Tumors.

Neoplasms
Pacira Pharmaceuticals, Inc

Unknown

Chemotherapy in Treating Young Patients With Recurrent or Refractory Meningeal Leukemia, Lymphoma, or Solid Tumors

Lymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Leukemia | Brain and Central Nervous System Tumors

Canada, United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Graft Versus Host Disease

United States
University of Arizona
National Cancer Institute (NCI)

Completed

Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous/Nonmalignant Condition

United States
Celgene Corporation
Prologue Research International

Completed

Expanded Access Program:Lenalidomide With or Without Dexamethasone In Previously Treated Subjects With Multiple Myeloma

Multiple Myeloma

United States, Canada
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

MS-275 in Treating Patients With Hematologic Cancer

Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome

Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative Diseases

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Lymphoma | Myelodysplastic Syndromes | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Completed

Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative Diseases

United States
Movetis

Completed

Study to Evaluate Long-Term Tolerability and Safety of Oral Prucalopride in Chronic Constipation

Chronic Constipation

Belgium
Ottawa Hospital Research Institute

Completed

Aromasin (Exemestane) in Patients With Recurrent or Refractory Stage II - IV Epithelial Ovarian Cancer

Ovarian Cancer

Canada
Bristol-Myers Squibb

Completed

MAD Refractory: Solid Tumor QD w/o Break

HER2 or EGFR Expressing Advanced Solid Malignancies

Spain, France
Virginia Commonwealth University
National Cancer Institute (NCI)

Completed

Bone Marrow Transplantation in Treating Patients With Leukemia, Myelodysplasia, or Lymphoblastic Lymphoma

Lymphoma | Myelodysplastic Syndromes | Leukemia

United States
Virginia Commonwealth University
National Cancer Institute (NCI)

Completed

Bryostatin + Fludarabine in Treating Patients With Chronic Lymphocytic Leukemia or Relapsed Indolent Non-Hodgkin's Lymphoma

Lymphoma | Leukemia

United States
National Cancer Institute, Naples

Completed

ZANTE: Zometa and Taxotere in Hormone Refractory Prostate Cancer (ZANTE)

Metastatic Prostate Cancer

Italy
National Institute of Neurology and Neurosurgery...
National Council of Science and Technology, Mexico

Completed

Thalidomide Low Threshold in Epilepsy

Refractory Epilepsy
Norgine

Completed

Constipation Associated With Irritable Bowel Syndrome (IBS-C)

Constipation

United Kingdom, Italy, Czech Republic, France, Germany, Poland, Sweden
Virginia Commonwealth University
National Cancer Institute (NCI)

Completed

Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or Lymphoma

Lymphoma | Leukemia

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

High-Dose Chemotherapy in Treating Patients Undergoing Stem Cell Transplant for Recurrent or Refractory Hodgkin's Lymphoma

Lymphoma
Bristol-Myers Squibb

Completed

Study of HIV Patients With Undetectable Viral Load and Abnormal Lipids Switching to Atazanavir/Ritonavir

HIV Infections

United States, Canada
University Hospital Inselspital, Berne

Completed

Brain Effects of Sacral Neuromodulation

Urinary Tract Disease

Switzerland
Bristol-Myers Squibb

Completed

A Study to Document Long-Term Safety and Continued Benefit of Irinotecan and Carboplatin or Irinotecan in Subjects With Refractory Solid Tumors (Rollover Study -001, -002)

Pediatric Solid Tumors
Institut Paoli-Calmettes

Unknown

Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders

Lymphoma | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Precancerous Condition | Graft Versus Host Disease

France
University of Medicine and Dentistry of New Jersey
National Cancer Institute (NCI)

Terminated

12-O-Tetradecanoylphorbol-13-acetate in Treating Patients With Hematologic Cancer or Bone Marrow Disorder

Lymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Multiple Myeloma and Plasma Cell Neoplasm | Myelodysplastic/Myeloproliferative Diseases | Precancerous/Nonmalignant Condition

United States
The SmartPill Corporation

Unknown

Colonic Transit Time Validation Study (CTT)

Constipation

United States, United Kingdom
St. John Health System, Michigan

Unknown

Methylnaltrexone for Treatment of Opiate-Induced Constipation in the Intensive Care Unit (MOVE-IT)

Opioid-induced Constipation

United States
Hospital y Clinica OCA, S.A. de C.V.

Unknown

CD133+ Cell Therapy for Refractory Coronary Heart Disease

Coronary Artery Disease

Mexico
National Institute of Diabetes and Digestive and...

Completed

Treatment of Functional Bowel Disorders

Irritable Bowel Syndrome | Abdominal Pain | Constipation | Functional Colonic Diseases

United States, Canada
National Institute of Diabetes and Digestive and...

Completed

North American Study for the Treatment of Refractory Ascites (NASTRA)

Liver Cirrhosis | Ascites

United States, Canada
National Institute of Diabetes and Digestive and...

Completed

Biofeedback for Dyssynergic Constipation

Constipation

United States
Mansoura University

Completed

Comparative Study Between Surgical and Non Surgical Treatment of Anismus in Patients

Constipation | Obstructed Defecation | Anismus

Egypt
Pfizer

Completed

SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma

Carcinoma, Renal Cell

United States
Royal Marsden NHS Foundation Trust

Completed

A Retrospective Review of Gemcitabine, Methylprednisolone Cisplatin (GEM-P) With or Without Rituximab in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Non-Hodgkins Lymphoma

United Kingdom
University of New Mexico

Completed

INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.

Cancer | Non-Hodgkin's Lymphoma

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Cellular Adoptive Immunotherapy in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma

Lymphoma

United States
University of California, San Francisco

Completed

Adding Malabsorption for Failed Gastric Bypass

Clinically Severe Obesity | Obesity Recidivism | Inadequate Initial Weight Loss | Poor Weight Loss | Persistent Obesity | Refractory Obesity | Intractable Obesity

United States
Samsung Medical Center

Unknown

Vorinostat Combined With Gemtuzumab Ozogamicin, Idarubicin and Cytarabine in Acute Myeloid Leukemia

Acute Myeloid Leukemia

Korea, Republic of
Huazhong University of Science and Technology
Qingdao University; Southern Medical University, China; Centers for Disease Control...

Unknown

Diet and Lifestyle Intervention Study in Postpartum Women in China

Constipation | Anemia | Fever | Hemorrhoids | Anal Fissure | Puerperal Infection | Breast Disease | Oral Ulcers

China
PharmaMar

Completed

A Study of Aplidin (Plitidepsin) 3 h iv in Subjects With Relapsing or Refractory Multiple Myeloma

Multiple Myeloma

United States
Beijing Chao Yang Hospital
Pfizer

Unknown

Intensive Statin Treatment for STEMI Patients Undergoing Primary PCI

STEMI

China
Royal Marsden NHS Foundation Trust

Completed

Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours

Upper Gastrointestinal Tumours

United Kingdom
Sanofi

Completed

Pharmacokinetics and Safety Study With Alfuzosin in Children and Adolescents With Elevated Detrusor Leak Point Pressure of Neuropathic Etiology (ALFACHIP)

Urinary Bladder Neurogenic

Serbia, United States

Search clinical trials for: refractory constipation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations